LGM

Logos Global Management Portfolio holdings

AUM $749M
1-Year Est. Return 18.94%
This Quarter Est. Return
1 Year Est. Return
+18.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$749M
AUM Growth
+$186M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
60
New
Increased
Reduced
Closed

Top Buys

1
+$47.8M
2
+$25.1M
3
+$24.4M
4
ARVN icon
Arvinas
ARVN
+$24.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.9M

Top Sells

1
+$35.5M
2
+$26.1M
3
+$21.8M
4
BNTX icon
BioNTech
BNTX
+$18.2M
5
ETNB icon
89bio
ETNB
+$18.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
1
IDEAYA Biosciences
IDYA
$2.43B
$70.3M 7.78%
3,345,000
-155,000
AKRO icon
2
Akero Therapeutics
AKRO
$4.3B
$64M 7.08%
1,200,000
RVMD icon
3
Revolution Medicines
RVMD
$9.29B
$62.5M 6.92%
1,700,000
+100,000
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$8.14B
$47.8M 5.28%
+450,000
IRON icon
5
Disc Medicine
IRON
$2.59B
$37.1M 4.1%
700,000
+305,658
RNA icon
6
Avidity Biosciences
RNA
$7.12B
$27M 2.99%
950,000
+600,000
KROS icon
7
Keros Therapeutics
KROS
$418M
$26.7M 2.95%
2,000,000
BIIB icon
8
Biogen
BIIB
$20.9B
$25.1M 2.78%
+200,000
UTHR icon
9
United Therapeutics
UTHR
$19.6B
$24.4M 2.7%
+85,000
ARVN icon
10
Arvinas
ARVN
$711M
$24.3M 2.69%
+3,300,000
JANX icon
11
Janux Therapeutics
JANX
$1.63B
$23.1M 2.56%
1,000,000
-650,000
OCUL icon
12
Ocular Therapeutix
OCUL
$2.59B
$20.4M 2.26%
2,200,000
-100,000
ERAS icon
13
Erasca
ERAS
$718M
$19.1M 2.11%
15,000,000
+2,000,000
NBIX icon
14
Neurocrine Biosciences
NBIX
$13.6B
$18.9M 2.09%
+150,000
DYN icon
15
Dyne Therapeutics
DYN
$2.34B
$18.1M 2%
1,900,000
+1,400,000
IMCR icon
16
Immunocore
IMCR
$1.69B
$18M 2%
+575,000
GPCR icon
17
Structure Therapeutics
GPCR
$1.59B
$17.6M 1.95%
850,000
+425,000
MDGL icon
18
Madrigal Pharmaceuticals
MDGL
$9.85B
$15.1M 1.67%
+50,000
DSGN icon
19
Design Therapeutics
DSGN
$351M
$14.2M 1.57%
4,217,627
KRYS icon
20
Krystal Biotech
KRYS
$5.45B
$13.7M 1.52%
+100,000
OLMA icon
21
Olema Pharmaceuticals
OLMA
$659M
$13.7M 1.51%
3,208,875
CLDX icon
22
Celldex Therapeutics
CLDX
$1.76B
$12.2M 1.35%
+600,000
BHVN icon
23
Biohaven
BHVN
$1.74B
$9.88M 1.09%
+700,000
XNCR icon
24
Xencor
XNCR
$1.07B
$9.82M 1.09%
+1,250,000
PRAX icon
25
Praxis Precision Medicines
PRAX
$3.42B
$9.46M 1.05%
+225,000
1
2 3